This content is machine translated Modern system therapeutics for hidradenitis suppurativa Immunological dysregulation in the sights of several biologics and “small molecules” The approval of anti-TNF and anti-IL-17 antibody therapies for moderate to severe courses of hidradenitis suppurativa has significantly improved the drug treatment options for this debilitating and potentially mutilating disease...…
View Post 8 min This content is machine translated Mastocytosis Innovative pathogenesis-based therapeutic approaches in the pipeline The treatment of mastocytosis has undergone a paradigm shift in recent years. A deeper molecular understanding of the disease has paved the way from a purely symptomatic to a targeted,...…
